ESj- Powder Complete T&A Study
NCT04488718 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2021-02-03
Summary
The goal of this study is to gather data on the tolerance and acceptability of a new ONS (ESj-powder complete) in children currently taking ONS.
Conditions
- Child Nutrition Disorders
- Child Malnutrition
Interventions
- OTHER
-
EnergieShake® Junior Powder Complete
Oral Nutritional Supplement
Sponsors & Collaborators
-
Brighton and Sussex University Hospitals NHS Trust
collaborator OTHER -
Great Ormond Street Hospital for Children NHS Foundation Trust
collaborator OTHER -
The Leeds Teaching Hospitals NHS Trust
collaborator OTHER -
Anaiah Healthcare Pvt Ltd
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-24
- Primary Completion
- 2021-04-24
- Completion
- 2021-05-24
Countries
- United Kingdom
Study Locations
More Related Trials
-
Nutritional Tolerance and Safety of a Tube Feeding Formula
NCT05848583 ·Status: TERMINATED ·Phase: NA
-
Elemental 028 Extra Case Studies
NCT06877923 ·Status: RECRUITING ·Phase: NA
-
Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets
NCT01237288 ·Status: COMPLETED ·Phase: PHASE3
-
Acceptability and Tolerance Study of a High Energy Tube Feed with Food Derived Ingredients
NCT06034951 ·Status: COMPLETED ·Phase: NA
-
Using Commonly Available Food Products To Treat Food Allergy
NCT05503446 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Plasma Exchange for Amanita Toxin-induced Acute Liver Failure
NCT06187220 ·Status: COMPLETED
-
Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
NCT02784392 ·Status: COMPLETED ·Phase: PHASE2
-
Repurposing Empagliflozin for DMD-associated Cardiomyopathy in Children 6-18 Years of Age
NCT06643442 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
NCT02682381 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Teduglutide in Japanese Participants With Short Bowel Syndrome
NCT03663582 ·Status: COMPLETED ·Phase: PHASE3
-
An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients
NCT00666393 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)
NCT02340819 ·Status: COMPLETED ·Phase: PHASE3
-
Anabolic Steroids for Nutritional Rehabilitation of Critically Ill Patients
NCT00242463 ·Status: TERMINATED ·Phase: PHASE2
-
Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis
NCT04733066 ·Status: UNKNOWN
-
A Single Arm Intervention Study to Assess the Acceptability, Tolerance and Ease of Use of Wilbo's Blends+ (Commercial Enteral Feed Based on Real Food) When Used as Part of a Dietitian Prescribed Enteral Feeding Plan
NCT07036081 ·Status: COMPLETED ·Phase: NA
-
Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support
NCT02980666 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302
NCT03268811 ·Status: COMPLETED ·Phase: PHASE3
-
Safety During Use of Paediatric Triple Chamber Bag Formulas
NCT01304394 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome
NCT01952080 ·Status: COMPLETED ·Phase: PHASE3
-
Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency
NCT02094430 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Longterm HPN With Two Lipid Emulsions
NCT00530738 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older
NCT05027308 ·Status: COMPLETED ·Phase: PHASE3
-
Neuromuscular Electrical Stimulation for Children With Dysphagia
NCT06309056 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)
NCT07285369 ·Status: TERMINATED ·Phase: NA
-
Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis
NCT01234883 ·Status: TERMINATED ·Phase: PHASE4